WO1992018197A1 - Device for carrying out an iontophoresis treatment on a patient - Google Patents

Device for carrying out an iontophoresis treatment on a patient Download PDF

Info

Publication number
WO1992018197A1
WO1992018197A1 PCT/NL1992/000077 NL9200077W WO9218197A1 WO 1992018197 A1 WO1992018197 A1 WO 1992018197A1 NL 9200077 W NL9200077 W NL 9200077W WO 9218197 A1 WO9218197 A1 WO 9218197A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
patient
signal
treatment signal
duty cycle
Prior art date
Application number
PCT/NL1992/000077
Other languages
French (fr)
Inventor
John Van Groningen
Original Assignee
B.V. Optische Industrie 'de Oude Delft'
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B.V. Optische Industrie 'de Oude Delft' filed Critical B.V. Optische Industrie 'de Oude Delft'
Priority to EP92909753A priority Critical patent/EP0537320B1/en
Priority to DE69201850T priority patent/DE69201850T2/en
Priority to JP4509298A priority patent/JPH06503496A/en
Priority to US07/962,196 priority patent/US5391195A/en
Publication of WO1992018197A1 publication Critical patent/WO1992018197A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Definitions

  • the invention relates to a device for carrying out an iontophoresis treatment on a patient, provided with a signal generator for generating a treatment signal and an output stage which can be connected to the patient by means of two electrodes.
  • Such devices are known in various embodiments. With the aid of an iontophoresis treatment, it is pos- sible to introduce electrically charged particles into a patient's body by means of the treatment signal. In this way it is possible to introduce a drug locally into the body. Under these circumstances, the guantity of sub ⁇ stance introduced into the body is essentially propor- tional to the product of the treatment current and the time. In the standard devices of this type, various kinds of treatment signals are used but they all have disadvantages.
  • a known treatment signal is formed by an uninter- rupted direct current, which has the drawback that a severe burning sensation is induced in the patient by this current form, which can very rapidly result in cauterisation of the patient's skin, either over a large area under the entire electrode or as a local so-called point cauterisation.
  • the maximum permissible current density of the treatment signal is very low and in practice it is assumed that a maximum value of 0.2 mA/cm 2 is still safe.
  • the treatment signal in this form causes such a high skin stress that a daily repetition of the treatment is virtually ruled out.
  • Another known treatment signal is formed by a pulse current in the form of a half-wave or full-wave rectified sinusoidal signal, which also has the drawback that a burning sensation can be induced in the patient and cauterisation of the skin also occurs.
  • the duty cycle of said signal is appreciably less than 100%, as a result of which a relatively small guantity of substance can be introduced into the body per unit time, with the result that a longer treatment time is necessary and, consequently, a high skin stress occurs again.
  • the treatment signal in this form has the drawback that such current forms are usually also used for other therapies, with the result that a combination effect occurs, the consequences of which are incalculable.
  • a device is also known in which a treatment signal is generated which comprises a depolari ⁇ sing alternating current which is made up of a positive pulse and a smaller negative pulse or vice versa.
  • the duty cycle of this treatment signal is appreciably less than 100%, as a result of which long treatment times and high current densities are necessary.
  • the negative pulse would result in an inverse effect to the positive pulse, thereby reducing the efficiency of the treatment further.
  • the object of the invention is to provide a device of the type mentioned in the introduction, in which the disadvantages mentioned are eliminated in a simple and expedient manner.
  • the device according to the invention has the characteristic that the signal gen ⁇ erator generates as treatment signal a pulsed direct current with a duty cycle of at least 80%.
  • a device is obtained which makes possible a particularly expedient iontophoresis treatment of the patient, with a high efficiency for the introduc ⁇ tion of the substance being achieved by the relatively high duty cycle.
  • the treatment signal generated by the device according to the invention does not induce any burning sensation in the patient, with the result that a relatively high current density can be used and, consequently, more substance can be introduced in the same treatment time. In practical tests it has been found that no cauterisation of the skin occurs. As a result of the low skin stress, the patient can be treated regularly, if necessary daily.
  • Figure 1 is a highly simplified block diagram of an embodiment of the device according to the invention.
  • Figure 2 shows the current form of the treatment signal of the device according to Figure 1.
  • Figure 1 shows a highly simplified block diagram of a device for carrying out an iontophoresis treatment on a patient, which device is provided with a signal generator 1 for generating a treatment signal and an output stage 2 which can be connected to the patient by means of two diagrammatically indicated electrodes 3.
  • the output of the output stage 2 is designed as a current source.
  • the treatment signal generated by the signal generator 1 is a pulsed direct current or rectangular pulse train, the on/off ratio or duty cycle of the signal per cycle being very high, that is to say at least 80%.
  • the current density, the frequency and the duty cycle of the treatment signal can be set by means of a suitable setting device 4, 5 or 6, respectively.
  • the duty cycle can preferably be set between 90 and 98%. Satisfactory treatment results can already be achieved with a duty cycle of at least 80%.
  • the frequency of the treatment signal can be set by means of the setting device 5 to a value upwards of at least 1 kHz and is preferably set in the region of 4-8 kHz.
  • the current density of the treatment signal can, without difficulty, be set a factor of 5 or more higher than in the known device, that is to say to a value of 1 mA/cm 2 or higher.
  • the treatment signal in this form has important advantages.
  • the duty cycle can be very high, in the region of 90-98%, as a result of which a high efficiency is achieved in the introduction of substances into the body by means of the treatment. No burning sensation occurs in the patient, with the result that high current densities can be used, as a result of which more drug can be introduced into the patient in a certain treatment period than is possible in the case of the known device. Tests have shown that no cauterisation of the skin occurs. As a result, the treatment can be carried out much more frequently, if necessary even daily.

Abstract

A device for carrying out an iontophoresis treatment on a patient is provided with a signal generator for generating a treatment signal and an output stage which can be connected to the patient by means of two electrodes. The signal generator generates as treatment signal a pulsed direct current with a duty cycle of at least 80 %.

Description

Title: Device for carrying out an iontophoresis treatment on a patient
The invention relates to a device for carrying out an iontophoresis treatment on a patient, provided with a signal generator for generating a treatment signal and an output stage which can be connected to the patient by means of two electrodes.
Such devices are known in various embodiments. With the aid of an iontophoresis treatment, it is pos- sible to introduce electrically charged particles into a patient's body by means of the treatment signal. In this way it is possible to introduce a drug locally into the body. Under these circumstances, the guantity of sub¬ stance introduced into the body is essentially propor- tional to the product of the treatment current and the time. In the standard devices of this type, various kinds of treatment signals are used but they all have disadvantages.
A known treatment signal is formed by an uninter- rupted direct current, which has the drawback that a severe burning sensation is induced in the patient by this current form, which can very rapidly result in cauterisation of the patient's skin, either over a large area under the entire electrode or as a local so-called point cauterisation. As a result, the maximum permissible current density of the treatment signal is very low and in practice it is assumed that a maximum value of 0.2 mA/cm2 is still safe. As a result, only a small amount of substance can be introduced into the patient's body per unit time and the treatment takes a relatively long time. In addition, the treatment signal in this form causes such a high skin stress that a daily repetition of the treatment is virtually ruled out.
Another known treatment signal is formed by a pulse current in the form of a half-wave or full-wave rectified sinusoidal signal, which also has the drawback that a burning sensation can be induced in the patient and cauterisation of the skin also occurs.
Moreover, the duty cycle of said signal is appreciably less than 100%, as a result of which a relatively small guantity of substance can be introduced into the body per unit time, with the result that a longer treatment time is necessary and, consequently, a high skin stress occurs again. In addition, the treatment signal in this form has the drawback that such current forms are usually also used for other therapies, with the result that a combination effect occurs, the consequences of which are incalculable.
Finally, a device is also known in which a treatment signal is generated which comprises a depolari¬ sing alternating current which is made up of a positive pulse and a smaller negative pulse or vice versa. The duty cycle of this treatment signal is appreciably less than 100%, as a result of which long treatment times and high current densities are necessary. In addition, the negative pulse would result in an inverse effect to the positive pulse, thereby reducing the efficiency of the treatment further.
The object of the invention is to provide a device of the type mentioned in the introduction, in which the disadvantages mentioned are eliminated in a simple and expedient manner.
For this purpose, the device according to the invention has the characteristic that the signal gen¬ erator generates as treatment signal a pulsed direct current with a duty cycle of at least 80%. In this manner, a device is obtained which makes possible a particularly expedient iontophoresis treatment of the patient, with a high efficiency for the introduc¬ tion of the substance being achieved by the relatively high duty cycle. Surprisingly, it has been found that the treatment signal generated by the device according to the invention does not induce any burning sensation in the patient, with the result that a relatively high current density can be used and, consequently, more substance can be introduced in the same treatment time. In practical tests it has been found that no cauterisation of the skin occurs. As a result of the low skin stress, the patient can be treated regularly, if necessary daily.
The invention is explained in greater detail below with reference to the drawing, which shows an exemplary embodiment. Figure 1 is a highly simplified block diagram of an embodiment of the device according to the invention.
Figure 2 shows the current form of the treatment signal of the device according to Figure 1.
Figure 1 shows a highly simplified block diagram of a device for carrying out an iontophoresis treatment on a patient, which device is provided with a signal generator 1 for generating a treatment signal and an output stage 2 which can be connected to the patient by means of two diagrammatically indicated electrodes 3. As is indicated in Figure 1, the output of the output stage 2 is designed as a current source. The treatment signal generated by the signal generator 1 is a pulsed direct current or rectangular pulse train, the on/off ratio or duty cycle of the signal per cycle being very high, that is to say at least 80%.
The current density, the frequency and the duty cycle of the treatment signal can be set by means of a suitable setting device 4, 5 or 6, respectively. In this connection, the duty cycle can preferably be set between 90 and 98%. Satisfactory treatment results can already be achieved with a duty cycle of at least 80%.
The frequency of the treatment signal can be set by means of the setting device 5 to a value upwards of at least 1 kHz and is preferably set in the region of 4-8 kHz.
Tests have shown that the current density of the treatment signal can, without difficulty, be set a factor of 5 or more higher than in the known device, that is to say to a value of 1 mA/cm2 or higher.
An example of the current form of the treatment signal of the device described is shown very diagram- matically in Figure 2, the cycle of the signal being indicated by T. It is pointed out that the current form will in practice differ more or less from the ideal square shape shown. The treatment signal in this form has important advantages. The duty cycle can be very high, in the region of 90-98%, as a result of which a high efficiency is achieved in the introduction of substances into the body by means of the treatment. No burning sensation occurs in the patient, with the result that high current densities can be used, as a result of which more drug can be introduced into the patient in a certain treatment period than is possible in the case of the known device. Tests have shown that no cauterisation of the skin occurs. As a result, the treatment can be carried out much more frequently, if necessary even daily.
The invention is not restricted to the embodiment described above, which may be varied in various ways within the scope of the invention.

Claims

Claims
1. Device for carrying out an iontophoresis treat¬ ment on a patient, provided with a signal generator for generating a treatment signal and an output stage which can be connected to the patient by means of two electrodes, characterised in that the signal generator generates as treatment signal a pulsed direct current with a duty cycle of at least 80%.
2. Device according to Claim 1, characterised in that the duty cycle of the treatment signal is 90-98%.
3. Device according to Claim 1 or 2, characterised in that the frequency of the treatment signal is at least 1 kHz.
4. Device according to Claim 2, characterised in that the frequency of the treatment signal is in the region of 4-8 kHz.
5. Device according to one of the preceding claims, characterised in that the output stage has an output which acts as current source.
6. Device according to one of the preceding claims, characterised in that the current density and, prefer¬ ably, the frequency and the duty cycle of the treatment signal can be set.
PCT/NL1992/000077 1991-04-17 1992-04-15 Device for carrying out an iontophoresis treatment on a patient WO1992018197A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP92909753A EP0537320B1 (en) 1991-04-17 1992-04-15 Device for carrying out an iontophoresis treatment on a patient
DE69201850T DE69201850T2 (en) 1991-04-17 1992-04-15 DEVICE FOR CARRYING OUT AN IONTOPHORETIC TREATMENT ON A PATIENT.
JP4509298A JPH06503496A (en) 1991-04-17 1992-04-15 Device for treating patients with iontophoresis
US07/962,196 US5391195A (en) 1991-04-17 1992-04-15 Device for carrying out an iontophoresis treatment on a patient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9100662 1991-04-17
NL9100662A NL9100662A (en) 1991-04-17 1991-04-17 DEVICE FOR PERFORMING AN ITHOPHORESIS TREATMENT ON A PATIENT.

Publications (1)

Publication Number Publication Date
WO1992018197A1 true WO1992018197A1 (en) 1992-10-29

Family

ID=19859142

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1992/000077 WO1992018197A1 (en) 1991-04-17 1992-04-15 Device for carrying out an iontophoresis treatment on a patient

Country Status (9)

Country Link
US (1) US5391195A (en)
EP (1) EP0537320B1 (en)
JP (1) JPH06503496A (en)
AT (1) ATE120378T1 (en)
DE (1) DE69201850T2 (en)
DK (1) DK0537320T3 (en)
ES (1) ES2072761T3 (en)
NL (1) NL9100662A (en)
WO (1) WO1992018197A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040365A1 (en) * 1995-06-07 1996-12-19 Alza Corporation Electrotransport agent delivery method and apparatus
WO1999030775A1 (en) * 1997-12-17 1999-06-24 Alza Corporation Iontophoresis with programmed adjustment of electric current
AU710793B2 (en) * 1995-06-07 1999-09-30 Alza Corporation Electrotransport agent delivery method and apparatus
US6496728B2 (en) 2000-02-18 2002-12-17 University Of Utah Research Foundation Methods for extracting substances using alternating current
US6512950B2 (en) 2000-02-18 2003-01-28 University Of Utah Research Foundation Methods for delivering agents using alternating current
US7136698B2 (en) 1996-06-07 2006-11-14 Alza Corporation Electrotransport agent delivery apparatus
US7137975B2 (en) 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956032B1 (en) * 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6148231A (en) * 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US6792306B2 (en) * 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6477410B1 (en) * 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US6553255B1 (en) 2000-10-27 2003-04-22 Aciont Inc. Use of background electrolytes to minimize flux variability during iontophoresis
US20030065285A1 (en) * 2001-07-23 2003-04-03 Higuchi William I. Method and apparatus for increasing flux during reverse iontophoresis
US20060254912A1 (en) * 2003-03-04 2006-11-16 Amos Nussinovitch System and method for treating biological tissue usiing curret electrical field
JP2020137721A (en) * 2019-02-27 2020-09-03 パナソニックＩｐマネジメント株式会社 Cosmetic device, and control unit of the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116238A (en) * 1976-08-18 1978-09-26 Midgard Electronics Company, Inc. High voltage constant current source for iontophoresis
US4167190A (en) * 1977-10-21 1979-09-11 Medtronic, Inc. Pulse dosage control unit for tissue stimulation system
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
EP0308572A2 (en) * 1983-09-01 1989-03-29 Hisamitsu Pharmaceutical Co., Inc. An iontophoresis device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4019510A (en) * 1975-02-10 1977-04-26 Sybron Corporation Therapeutic method of using low intensity direct current generator with polarity reversal
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US5088977A (en) * 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5047007A (en) * 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116238A (en) * 1976-08-18 1978-09-26 Midgard Electronics Company, Inc. High voltage constant current source for iontophoresis
US4167190A (en) * 1977-10-21 1979-09-11 Medtronic, Inc. Pulse dosage control unit for tissue stimulation system
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
EP0308572A2 (en) * 1983-09-01 1989-03-29 Hisamitsu Pharmaceutical Co., Inc. An iontophoresis device

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
WO1996040364A1 (en) * 1995-06-07 1996-12-19 Alza Corporation Electrotransport agent delivery method and apparatus
AU694371B2 (en) * 1995-06-07 1998-07-16 Alza Corporation Electrotransport agent delivery method and apparatus
AU701238B2 (en) * 1995-06-07 1999-01-21 Alza Corporation Electrotransport agent delivery method and apparatus
AU710793B2 (en) * 1995-06-07 1999-09-30 Alza Corporation Electrotransport agent delivery method and apparatus
WO1996040365A1 (en) * 1995-06-07 1996-12-19 Alza Corporation Electrotransport agent delivery method and apparatus
US7212853B1 (en) 1995-06-07 2007-05-01 Alza Corporation Electrotransport agent delivery method and apparatus
US7136698B2 (en) 1996-06-07 2006-11-14 Alza Corporation Electrotransport agent delivery apparatus
WO1999030775A1 (en) * 1997-12-17 1999-06-24 Alza Corporation Iontophoresis with programmed adjustment of electric current
US6219576B1 (en) 1997-12-17 2001-04-17 Alza Corporation Programmed adjustment of electric current to provide desired electrically assisted transdermal drug delivery rate
US6496728B2 (en) 2000-02-18 2002-12-17 University Of Utah Research Foundation Methods for extracting substances using alternating current
US6512950B2 (en) 2000-02-18 2003-01-28 University Of Utah Research Foundation Methods for delivering agents using alternating current
US7137975B2 (en) 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent

Also Published As

Publication number Publication date
ES2072761T3 (en) 1995-07-16
NL9100662A (en) 1992-11-16
EP0537320B1 (en) 1995-03-29
DE69201850D1 (en) 1995-05-04
US5391195A (en) 1995-02-21
DE69201850T2 (en) 1995-11-09
JPH06503496A (en) 1994-04-21
ATE120378T1 (en) 1995-04-15
EP0537320A1 (en) 1993-04-21
DK0537320T3 (en) 1995-08-07

Similar Documents

Publication Publication Date Title
US5391195A (en) Device for carrying out an iontophoresis treatment on a patient
US4124030A (en) Electro-therapeutic faradic current generator
JP2616757B2 (en) Apparatus for treating living bone tissue with a vibrating electromagnetic field
US4431002A (en) Modulated deep afferent stimulator
NZ531877A (en) Apparatus and method for bioelectric stimulation, healing acceleration and pain relief
ATE179339T1 (en) ELECTRICAL STIMULATION FOR THE TREATMENT OF INCONTINENCE AND OTHER NEUROMUSCULAR DISEASES
CA2010988A1 (en) Method of generating electric pulse for biologic objects stimulation and apparatus thereof
KR920703147A (en) Method and apparatus for delivering ion penetrating medicine in pulse state
EP0432240A1 (en) Electrical apparatus for medical treatment
IE912227A1 (en) Method and device for the treatment of epilepsy
US6512955B1 (en) Electrical apparatus for therapeutic treatment
US4442839A (en) Method of modulating energy in train of electrical pulses
US3295528A (en) Electrical therapeutic equipment
JP2003135607A (en) Low frequency medical treating system
JP2002515312A (en) Magnetic stimulator
FR2369850A1 (en) Medical appts. for ionising body tissues - uses electrical generator to provide square pulses to create potential difference in body cells
EP0269306A1 (en) Low-frequency treatment device directed to use in a bath
JPS61500594A (en) Non-invasive treatment method and circuit for implementing this method
WO1999006106A1 (en) Apparatus for electrical stimulation of a body
RU2011386C1 (en) Electrostimulator
JP2004113485A (en) Biostimulus device
EP0625361A2 (en) Very low frequency and very short duration sequential variable magnetic field generating system
RU2042364C1 (en) Device for applying wave reflexotherapy
RU2005507C1 (en) Device for electric analgesia
RU1813002C (en) Apparatus for electrotherapeutic treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

WWE Wipo information: entry into national phase

Ref document number: 1992909753

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992909753

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1992909753

Country of ref document: EP